MicroRNA Helps Prevent Tumors

MicroRNAs are tiny snippets of RNA that can repress activity of a gene by targeting the gene's messenger RNA (which copies DNA information and starts the process of protein production). The first microRNA was discovered in 1993, in worms. It took seven years for the second one to be found, also in worms, but then the floodgates burst. Many microRNAs now have been found in diverse plants and animals, including hundreds in humans. Moreover, microRNAs found in mammals regulate over a third of the human genome, as shown in a 2005 study by the lab of Whitehead Member and Howard Hughes Medical Institute Investigator David Bartel and colleagues. But given the wealth of microRNAs, and the ability of individual microRNAs to target hundreds of genes, researchers have struggled to show the biological impact of a particular microRNA on a particular target in mammals (although such connections have been shown in plants, worms and flies). Several groups have demonstrated that over-expression or under-expression of a microRNA can play a role in certain cancers, but have not clarified the genes responsible. Looking to find a promising target for an individual microRNA, Christine Mayr, a postdoctoral researcher in the Bartel lab, picked Hmga2, a gene that is defective in a wide range of tumors. In these tumors, the protein-producing part of the Hmga2 gene is cut short and replaced with DNA from another chromosome. Biologists have mostly focused on the shortened protein as the possible reason that the cells with this DNA swap became tumors. But this DNA swap removes not only the gene's protein-producing regions but also those areas that don't code for protein. And these non-protein-producing regions contain the elements that microRNAs recognize. .... Whole article: "www.sciencedaily.com":[ http://www.sciencedaily.com/releases/2007/02/070222155657.htm]

---

Related articles

Cheap molecule may attack tumors - A cheaply-produced molecule may be the key to treating a variety of cancers, claim Canadian researchers Dicholoroacetate (DCA) has been suggested for years as a possible treatment for certain rare metabolic disorders in children The University of Alberta team, writing in the journal Cancer Cell, now say it could encourage cancer cells to die Experts say much more research will be needed before an effective cancer treatment can emerge Whole article onnews (23.4.2007)

Genes Associated With Adverse Reactions To Cancer Radiotherapy Treatment Identified - Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment The research could mean people who might react badly to radiotherapy could be warned in advance or alternative treatments be sought The team who carried out the study included Drs Paul Symonds, Mark Plumb, Irene Peat and George Giotopoulos of the Department of Cancer Studies and Molecular Medicine and the Department of Genetics at the University of Leicester Whole article on ScienceDaily (21.4.2007)

Simulated Populations Used To Probe Gene Mapping - More powerful computers are allowing scientists and engineers to conduct simulations that grow more realistic each year In a new study published in the journal PLoS Genetics, statisticians and genetic epidemiologists from Rice University and The University of Texas M "In a real population, you never have the complete genetic picture, particularly for complex diseases where more than one gene is implicated and where environmental factors play a role," said lead author Bo Peng of M Whole article: www (27.3.2007)

New findings on the genomic guardian - p53 protein - The p53 protein routinely shuts down damaged cells and is one of our main lines of defence against cancer The p53 transcription factor is found in every cell of the body, where it helps to prevent cancer by activating and deactivating the right genes Almost half of all cancer tumours involve a mutation of the gene for p53, and in the hope of developing new cancer therapies, many cancer researchers study the mechanisms the protein controls read more www (22.3.2007)

Scientists look at precancerous cells - Researchers in Boston have identified how a missing protein causes tissue to become precancerous, the Massachusetts Institute of Technology announced The finding could help identify patients at risk of developing tumors, MIT said Most breast and prostate tumors are missing the protein but it has not been clear what role the protein, known as 14-3-3 sigma, played in tumor growth "The cells try to divide and try to divide, and they just give up Whole article: www (19.3.2007)